Metabolomic analysis suggests thiamine monophosphate as a potential marker for mesenchymal stem cell transplantation outcomes in patients with SLE
This study concludes that TMP is a potential biomarker that can predict the efficacy of MSCT in treating SLE, providing valuable insights for clinical practice and further research.
Authors
- Zhuoyang Jia (ORCID: https://orcid.org/0009-0004-4434-4830)
- Xiaojun Tang (ORCID: https://orcid.org/0000-0002-2442-1446)
- Xuebing Feng (ORCID: https://orcid.org/0000-0002-9837-9690)
- Lingyun Sun (ORCID: https://orcid.org/0000-0002-8563-2036)
- Bin Yang (ORCID: https://orcid.org/0009-0001-6453-8120)
- Xiaoman Jiang (ORCID: https://orcid.org/0009-0008-6663-5486)
Institutions
- Nanjing Drum Tower Hospital (CN)
Publication Details
- Journal
- Lupus Science & Medicine
- Published
- 2025-03-01
- DOI
- https://doi.org/10.1136/lupus-2024-001197
- Citations
- 6
- Primary Topic
- Alcoholism and Thiamine Deficiency
- Type
- article
- Field-Weighted Citation Impact
- 8.34
Funders
- National Key Research and Development Program of China